Primatene
- Product NDC
- 80070-600
- 11-digit product format
- 800700600
- Labeler code
- 80070
- Product ID
- 80070-600_2657d074-46cb-bc95-e063-6294a90aeec8
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- EPHEDRINE HYDROCHLORIDE
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Foundation Consumer Brands
- Application
- M012
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2021-01-22
- Substance
- EPHEDRINE HYDROCHLORIDE
- Active strength
- 12.5 mg/1
- Pharmacologic classes
- Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Increased Norepinephrine Activity [PE], Norepinephrine Releasing Agent [EPC], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Primatene
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| EPHEDRINE HYDROCHLORIDE | 12.5 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| NLJ6390P1Z | Internal UNII lookup |
Harmonized RxCUI identifiers#
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 2170f081-c03f-47e8-bc63-4052c5e653fa | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| d1bd959e-e326-44fb-b8ca-8c56a84a2a3d | Product name | 2 | 20251211 |
| f1d178e1-1663-4c63-ae37-62a1b322fba4 | Product name | 2 | 20251106 |
| f606d3ac-dd63-4b29-bea0-db23753b8ddc | Product name | 1 | 20220118 |
| 30254138-2d98-4aa2-8e07-ae82e8b0a389 | Product name | 3 | 20171103 |
| fee762de-ffd9-404d-8bc6-8c0c208e758d | Product name | 1 | 20170426 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 80070-600-24 | Primatene | 2 in 1 CARTON | TABLET | 2 | 2 | |
| 80070-600-24 | Primatene | 12 in 1 BLISTER PACK | TABLET | 12 | 2 | |
| 80070-600-60 | Primatene | 12 in 1 BLISTER PACK | TABLET | 12 | 2 | |
| 80070-600-60 | Primatene | 5 in 1 CARTON | TABLET | 5 | 2 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Mucus Relief Immediate Release | GUAIFENESIN 400MG | TopCo Associates, LLC | 7d91c6ab-d161-42b9-b353-0aa8f59619f8 | 2021-01-21 | Warnings | M012 |
| Daytime Cold and Flu | ACETAMINOPHEN 325MG/ DEXTROMETHORPHAN HBR 10MG/ PHENYLEPHRINE HCL 5MG | Allegiant Health | bed5f9dc-45ea-4e90-86c6-86599b6f3861 | 2020-11-16 | Warnings | M012 |
| Nighttime Cold and Flu Relief | ACETAMINOPHEN | Allegiant Health | b97126d7-847d-483e-b3d1-e2b61ab1743f | 2020-11-11 | Warnings | M012 |
| Cold and Allergy | PHENYLEPHRINE HCL AND CHLORPHENIRAMINE MALEATE | Allegiant Health | 7af63769-fa56-4f1f-a2ad-5b4c108c8e4f | 2019-12-12 | Warnings | M012 |
| Mucus Relief Immediate Release | GUAIFENESIN | Allegiant Health | 221d64a2-b8c7-435a-aae4-fb58fd38108f | 2019-03-26 | Warnings | M012 |
| Sleep Tabs For Nighttime use | DIPHENHYDRAMINE HCL TABLETS | Allegiant Health | 566e40b1-e9d7-44e4-b971-eef2b7cf0a7d | 2018-12-26 | Warnings | M012 |
| Allergy | CHLORPHENIRAMINE MALEATE | Allegiant Health | 4305ad50-d2a5-4d3e-9d92-cbf26e856a16 | 2018-12-26 | Warnings | M012 |
| Sleep Aid | DIPHENHYDRAMINE HCL 25 MG | Allegiant Health | dbbc535f-515a-4d9b-b799-34e60f5230bb | 2018-12-21 | Warnings | M012 |
| Allergy | DIPHENHYDRAMINE HCL | Allegiant Health | c2823bad-540f-4662-8dcc-58e9f0d94efb | 2018-11-07 | Warnings | M012 |
| Nasal Decongestant PE Maximum Strength Non-Drowsy | PHENYLEPHRINE 10 MG | Allegiant Health | 7aef00df-816a-4ea2-a2ad-beed66dd2fe4 | 2018-11-07 | Warnings | M012 |
| DEXTROMETHORPHAN HYDROBROMIDE, Guaifenesin, and PHENYLEPHRINE HYDROCHLORIDE | DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE | Westminster Pharmaceuticals, LLC | a58bfb14-28f9-4425-a5a5-aaff4847c979 | 2018-03-14 | Warnings | M012 |
| Chlorpheniramine maleate 4mg | CHLORPHENIRAMINE MALEATE 4MG | Athlete's Needs, Inc. | 4d974959-25fc-4707-9b72-9afbf47b76f1 | 2017-11-14 | Warnings | M012 |
| Cold Medicine | ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HCL | Selder, S.A. de C.V. | d2762d9c-e7e7-42b2-a26a-14b2aa0307cb | 2017-01-25 | Warnings | M012 |
| Allergy | CHLORPHENIRAMINE MALEATE | Marc Glassman, Inc. | 2051247f-ce64-4cf5-b449-9ca14c43ab86 | 2016-12-27 | Warnings | M012 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 2534871 | ePHEDrine HCl 12.5 MG Oral Tablet | PSN | 2170f081-c03f-47e8-bc63-4052c5e653fa | 2 |
| 2591390 | Primatene with ePHEDrine 12.5 MG Oral Tablet | PSN | 2170f081-c03f-47e8-bc63-4052c5e653fa | 2 |
| 2591390 | ephedrine hydrochloride 12.5 MG Oral Tablet [Primatene with ephedrine] | SBD | 2170f081-c03f-47e8-bc63-4052c5e653fa | 2 |
| 2534871 | ephedrine hydrochloride 12.5 MG Oral Tablet | SCD | 2170f081-c03f-47e8-bc63-4052c5e653fa | 2 |
| 2534871 | ephedrine HCl 12.5 MG Oral Tablet | SY | 2170f081-c03f-47e8-bc63-4052c5e653fa | 2 |
| 2591390 | Primatene with ephedrine 12.5 MG Oral Tablet | SY | 2170f081-c03f-47e8-bc63-4052c5e653fa | 2 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 80070-600-24 | 80070060024 | 2 BLISTER PACK in 1 CARTON (80070-600-24) / 12 TABLET in 1 BLISTER PACK | 2 blister pack | 2021-01-22 | 0000-00-00 | No | No | Current |
| 80070-600-60 | 80070060060 | 5 BLISTER PACK in 1 CARTON (80070-600-60) / 12 TABLET in 1 BLISTER PACK | 5 blister pack | 2021-01-22 | 0000-00-00 | No | No | Current |